Navigation Links
BioMS Medical Announces 2008 Year End Results
Date:3/17/2009

and development expenses for the year ended December 31, 2008 totaled $46.5 million compared with $38.9 million in 2007. Research and development expenses were $13.9 million for the three months ended December 31, 2008 compared to $9.3 million for the same quarter the previous year. The increase in expenses was the net result of: achieving full enrolment of clinical sites and patients in the MAESTRO-03 trial; increased costs for the MAESTRO-02 trial as patients enter the trial; reduced costs of the MAESTRO-01 and MINDSET-01 trials as more patients complete these trials; a decrease in drug manufacturing expenses as the manufacture of validation batches is completed; a licensing bonus payment related to the Agreement with Lilly, and; additional expenses related to alliance management and support.

At December 31, 2008, cash and cash equivalents and short-term investments totaled $90.4 million as compared to $37.9 million at December 31, 2007. At December 31, 2008, the Company had working capital of $81.3 million as compared to $32.8 million at December 31, 2007. Management estimates that the current working capital is sufficient for the Company to meet its obligations in respect of the currently initiated clinical trials.

As at December 31, 2008 there were 91,009,323 Class "A" common shares of the Company issued and outstanding.

    About BioMS Medical Corp.
    -------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for Secondary Progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchan
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. BioMS Medical warrant extension
2. BioMS Medical to present at BIO CEO and Investor Conference
3. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
4. BioMS Medical recognized at Scrip Awards 2008
5. BioMS Medical Announces Third Quarter 2008 Results
6. BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
7. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
8. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
9. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. BioMS Medical to present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... August 27, 2014 “We are honored ... vendors,” said Ven Thangaraj, CEO of Radiant Sage. “We ... are taking the imaging corelab market to a different ... and research organizations to efficiently and effectively manage the ... data to be analyzed and read by trained physicians. ...
(Date:8/27/2014)... , Aug. 27, 2014 Reportbuyer.com has ... The Graphene Opportunity - A Rational View ... The New Nanotech? A similar amount of ... applications ranging from microelectronics to water treatment, but ... the availability of the Graphene Opportunity Report, authored ...
(Date:8/27/2014)... 27, 2014 Research and Markets ... for Pulp & Paper Industry Report 2014" report ... for Pulp & Paper Industry Report 2014 is a ... the global enzyme for pulp & paper industry. ... industry including definitions, classifications, applications and industry chain structure. ...
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
Breaking Biology Technology:Radiant Sage Named to CIOReview List of 100 Most Promising Technology Companies 2The Graphene Opportunity - A Rational View 2The Graphene Opportunity - A Rational View 3The Graphene Opportunity - A Rational View 4Global Enzyme for Pulp & Paper Industry Report 2014 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3
... Jolla, Calif. -- Stratagene Corp. will appeal the jury ... company last week. , ,Stratagene on Saturday announced its move ... United States District Court for the Western District of Wisconsin. ... damages. , ,Stratagene said in a news release that it ...
... mantra for student technology usage on campus, according to ... to surpass desktop computers and an expanding interest in ... Survey, which randomly polled 1,600 students last spring, looked ... future areas of need. The survey is sponsored by ...
... Madison professor emeritus Larry Landweber, who was involved in one ... his expertise on the next stage of the Internet, which ... Computer & Information Science & Engineering (CISE) branch ... research project that may lead to the next generation of ...
Cached Biology Technology:Stratagene to appeal verdict won by Third Wave 2Student survey shows surging demand for wireless access 2Madison professor emeritus will consult on development of 'Internet 2' 2Madison professor emeritus will consult on development of 'Internet 2' 3
(Date:8/28/2014)... Munich have assigned a number of 435-million-year-old fossils ... animals lived in shallow marine habitats and were ... Jurassic strata. , Before they sank to ... were fossilized some 435 million years ago, these ... seas although they were not exactly inconspicuous, ...
(Date:8/27/2014)... bears, giant ground sloths, saber-toothed cats and American camels ... at the end of the Pleistocene period. The cause ... scientists who, until recently, could only speculate as to ... Barbara,s James Kennett, professor emeritus in the Department of ... played a major role in the extinction. Their hypothesis ...
(Date:8/27/2014)... N.C. -- Duke University researchers have identified a gene ... called OSCA1, encodes a protein in the cell membrane ... adjusts the plant,s water conservation machinery accordingly. , ... associate professor of biology at Duke. , The ... Nature , could make it easier to feed the ...
Breaking Biology News(10 mins):Paleontology: Oldest representative of a weird arthropod group 2Nanodiamonds are forever 2Nanodiamonds are forever 3Water 'thermostat' could help engineer drought-resistant crops 2
... satellite data and climate models have projected drier conditions ... States in coming decades. Other findings about U.S. wildfires, ... length and strength of fire seasons are expected to ... at the annual meeting of the American Geophysical Union ...
... T.J. Tabasco, a pig from the University of Illinois South ... by an international consortium. It is expected to speed progress ... President for Research Lawrence Schook said that the College of ... Funding that came through ACES allowed Schook and others ...
... 4, 2012 - The 2010 blowout of the Macondo well ... the region,s largest oil spill in U.S. history. As the ... the oil from coming to the surface and reaching coastal ... These powerful dispersants, typically used to break up oil slicks ...
Cached Biology News:Climate models project increase in US wildfire risk 2Climate models project increase in US wildfire risk 3Hogging the spotlight: South Farms pig gets international attention 2Numerical study suggests subsea injection of chemicals didn't prevent oil from rising to sea surface 2Numerical study suggests subsea injection of chemicals didn't prevent oil from rising to sea surface 3
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
... A modified nucleotide structure called ... 5?-end of most naturally-occurring eukaryotic mRNAs ... Cap Analog for a portion of ... vitro transcription reaction results in the ...
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
... Refrigerated Console Orbital Shakers combine high ... unequalled programming power. The patented ... the unit to run with heavy ... filtration system reduces contamination. The ...
Biology Products: